Roblee P. Allen, M.D.
- Medical Director of the Advanced Lung Disease/Lung Transplant Program
Philosophy of Care
I find myself in the best of both worlds. I left private practice in order to join academic medicine. This has afforded me the opportunity to become a research fellow sponsored by the American Lung Association and the NIH, the director of the Medical/Surgical Intensive Care Unit, and director of the Invasive Procedures in the Pulmonary Services Laboratory at UC Davis Medical Center. I have the opportunity to treat complex diseases in critically ill patients using state-of-the-art technology and investigative measures that are available only in the academic setting. This year, as a transplant physician, I participated in our rapidly growing Lung Transplant Program. I am especially excited that now I can make this kind of practice available to the community.
Roblee Allen is an expert in advanced-stage lung disease and lung transplantation. His clinical interests include functionality of lung volume reduction surgery, effects of anti-rejection drugs following lung transplantation, chronic obstructive pulmonary disease, acute respiratory distress syndrome, and cystic fibrosis. His pulmonary expertise and skill in mountain climbing led to his selection as team physician for the 1993 K2 West Ridge and 1995 Makalu Himalayan Southeast Ridge expeditions. Dr. Allen's extensive research studies include effects of high-carbohydrate diet on acute mountain sickness and circulating cytokines, effects of therapeutic drugs on community-acquired pneumonia, cellular responses of bronchial and esophageal carcinomas to photodynamic therapy, treatments for gram-negative septic shock, and pharmacokinetics and iatrogenic drug toxicities in intensive-care units.
M.D., Medical University of South Carolina, Charleston, South Carolina, 1978
M.S., University of South Carolina, Columbia, South Carolina, 1974
B.S., Wofford College, Spartanburg, South Carolina, 1972
Tulane University Affiliated Hospitals, New Orleans, Louisiana, 1979-80
University of California, Davis Medical Center, Sacramento, California, 1982-85
American Board of Internal Medicine, 1981
American Board of Internal Medicine, Critical Care Medicine, 1997
American Board of Internal Medicine, Pulmonary Disease, 1984
American College of Chest Physicians
Society of Critical Care Medicine
Select Recent Publications
Avdalovic, M., C. Sandrock, A. Hoso, R. Allen and T.E. Albertson. Epoprostenol in pregnant patients with secondary pulmonary hypertension: Two case reports and a review of the literature. Treat Resp Med 3:29-34.
Chan, A.L. and R.P. Allen. Bronchiolitis obliterans: An update. Current Opinion in Pulmonary Medicine 10:133-141, 2004.
Chan, A.L., M.M. Juarez, T.E. Albertson, B.M. Morrissey, R.P. Allen, and F.J. Meyers. Laser treatment of endobronchial renal cell carcinoma. Journal of Bronchology, 2004.
Laohaburanakit, P., A. Chan, and R.P. Allen. Bronchiolitis obliterans. Clin Rev in Allergy & Immunol 25:259-274, 2004.
Evans, S.J., R.P. Allen, S.S. Aghili, and A.L. Chan. Bronchoscopic Management of an Endobronchial Primary Paraganglionoma. Journal of Bronchology 10:118-121, 2003.
Chan, A. L., K. Y. Yoneda, R. P. Allen, and T. E. Albertson. Advances in the management of endobronchial lung malignancies. Current Opinions in Pulmonary Medicine 9:301-302, 2003.
Herbrecht, R., D.W. Denning, T.F. Patterson, J.E. Bennett, R.E. Greene, J.-W. Oestmann, V.K. Winfried, K.A. Marr, P. Ribaud, O. Lortholary, R. Sylvester, R.H. Rubin, J.R. Wingard, P. Stark, C. Durand, D. Caillot, E. Thiel, P.H. Chandrasekar, M.R. Hodges, H.T. Schlamm, P.F. Troke, B. de Pauw, for the Invasive Fungal Infections Group of the European Organization for Research and Treatment of Cancer and the Global Aspergillus Study Group. Voriconazole versus Amphotericin B for primary therapy of invasive aspergillosis. The New England Journal of Medicine 347:408-415, 2002.
Hardin, K.A., T.E. Albertson and R.P. Allen. An endobronchial cyst with squamous metaplasia at the location of an airway stent. Journal of Bronchology 8:193-196. 2001
Talebian, M., K.Y. Yoneda and R.P. Allen. Treatment of malignant airway obstruction with YAG laser photo resection. Journal of Bronchology 8:207-208. 2001
Harkin, C.P., N.J. Kenyon, R.P. Allen. Sudden intraoperative airway obstruction in a 65-year-old man. Journal of Respiratory Diseases 21:501-503. 2000
Albertson, T.E., B. Van Hoozen, G.P. Marelich and R.P. Allen. Pulmonary abnormalities, p. 218-229. In: (M.D. Ford, K.A. Delaney, L.J. Ling and T. Erickson, Eds.) Clinical Toxicology. W. B. Saunders Company. Philadelphia. 2000
Hong, L., S.J. Jahr, A. Thornton, R. Allen. Use of laryngeal mask airway in a patient requiring continuous positive airway pressure: A case report. Journal of Clinical Anesthesia 11:490-493. 1999
Follette, D., S. Rudich, C. Bonacci, R. Allen, A. Hoso, and T. Albertson. Importance of an Aggressive multidisciplinary management approach to optimize lung donor procurement. Transplantation Proceedings (31):169-170. 1999
Mercer, K., D. Follette, E. Bresline, R. Allen, A. Hoso, B. Voltz, and T. Albertson. Comparison of functional state between bilateral lung volume reduction surgery and pulmonary rehabilitation: A six-month followup study Journal of Surgical Investigation 1(2):130-147. 1999
Roberts P, Follette D, Allen R, Katznelson S, Albertson T. Cyclosporine A-associated thrombotic thrombocytopenic purpura following lung transplantation. Transplantation Proceedings 1998;30:1512-1513.
Swenson ER, MacDonals A, Vatheuer M, Maks C, Treadwell A, Allen R, Shoene RB. Acute mountain sickness is not altered by a high carbohydrate diet nor associated with elevated circulating cytokines. Aviation, Space, and Environmental Medicine 1997;68(6):449-503.
Albertson TE, Van Hoozen BE, Allen R. Amphetamines, p.560-568. In: Haddad LM, Shannon MW, Winchester JF (Eds.), Clinical Management of Poisoning and Drug Overdose, 3rd Edition, W.B. Saunders Company, Philadelphia, 1997.
Waldron J, Hanowell LH, Allen R. Lasers and the shared airway, Chapter 25 p 411-426. In: Hanowell LH and Waldron RJ (Eds.), Airway Management. Lippincott-Raven, Philadelphia, 1996.
Albertson TE, Walby WF, Allen RP, Tharratt RS. The pharmacology and toxicology of three new biologic agents used in pulmonary medicine. Clinical Toxicology 1995;33(5):427-438.